Author: Patrick Hathaway - Page 3

Learn how to recognize and manage rare but serious insulin allergies, from mild skin reactions to life-threatening anaphylaxis. Find out what causes them, how they're diagnosed, and what treatments actually work.

Over 400 medications can trigger dangerous heart rhythm problems. Learn the warning signs - like palpitations and dizziness - and what to do if you're at risk from common drugs like antibiotics, antidepressants, or diuretics.

Learn how to choose between overseas and domestic manufacturing for generic drugs by weighing cost, quality, lead times, and supply chain risks. Real data, expert insights, and practical strategies for generic drug producers.

The FDA doesn't rate biosimilars like generics-they undergo a rigorous, science-based approval process to prove they're highly similar to reference biologics. Learn how biosimilars are evaluated, approved, and listed in the FDA Purple Book.

Heat and humidity can destroy medication potency long before expiration dates. Learn which drugs are most at risk, where to store them safely, and why damaged meds can be dangerous-even if they look fine.

Pharmacists play a critical role in spotting generic drug problems like therapeutic inequivalence and adverse reactions. Learn what to report, how to report it, and why your input matters to patient safety.

Anti-inflammatory eating patterns like the Mediterranean and AIP diets can reduce inflammation and improve symptoms in autoimmune diseases. Evidence shows lower CRP levels, fewer flares, and less reliance on medication when whole foods replace processed ones.

Crossover trial design is the gold standard for bioequivalence studies, using each participant as their own control to compare generic and brand drugs with fewer subjects and higher accuracy. Learn how washout periods, replicate designs, and regulatory standards ensure reliable results.

Switching generic phenytoin products can be dangerous due to its narrow therapeutic range and non-linear metabolism. Learn when and why therapeutic drug monitoring is critical to avoid seizures or toxicity.

Partial AUC is a precise pharmacokinetic tool used by the FDA and EMA to ensure generic drugs match brand-name versions in how quickly they release medicine - especially for extended-release and abuse-deterrent formulations.